0001214659-18-000586.txt : 20180122
0001214659-18-000586.hdr.sgml : 20180122
20180122180032
ACCESSION NUMBER: 0001214659-18-000586
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180118
FILED AS OF DATE: 20180122
DATE AS OF CHANGE: 20180122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CARTER BRUCE L A
CENTRAL INDEX KEY: 0001225503
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 18540708
MAIL ADDRESS:
STREET 1: C/O ZYMOGENETICS, INC.
STREET 2: 1201 EASTLAKE AVENUE
CITY: SEATTLE
STATE: WA
ZIP: 98102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirati Therapeutics, Inc.
CENTRAL INDEX KEY: 0001576263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462693615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-332-3410
MAIL ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
marketforms-40822.xml
PRIMARY DOCUMENT
X0306
4
2018-01-18
0001576263
Mirati Therapeutics, Inc.
MRTX
0001225503
CARTER BRUCE L A
C/O MIRATI THERAPEUTICS, INC
9393 TOWNE CENTRE DRIVE, STE 200
SAN DIEGO
CA
92121
true
false
false
false
Non-Qualified Stock Option (right to buy)
27
2018-01-18
4
A
false
10000
0
A
2028-01-17
Common Stock
10000
10000
D
The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant.
/s/ Vickie Reed, Attorney-in-Fact
2018-01-22